Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Expands Smart Cycler Distribution Agreement with Fisher Scientific

NNEW YORK, Feb. 10 - Cepheid of Sunnyvale, Calif., has expanded a distribution agreement with Fisher Scientific for its Smart Cycler DNA sequence detection instrument, Cepheid said today.

 

Fisher will now have non-exclusive rights to distribute the Smart Cycler in the USlife science research, environmental, pharmaceutical quality control, IVF quality control, and cosmetics quality control markets, but will not have rights to distribute the instrument in the bio-threat market, the company said.

 

The agreement expires in May 2004. Previously, Fisher Scientific was the exclusive distributor of Cepheid Smart Cycler systems in the USlife science research market, above certain minimum purchase levels.

 

The agreement complements Cepheid's direct sales efforts in the USlife science markets, as well as its distributions agreements in Europewith Izasa SA and Bucher (Switzerland); and Diagnostic Technology Pty in Australiaand New Zealand.

 

Cepheid launched its SmartCycler II last December.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.